Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Ending HIV epidemics among people who inject drugs in LMICs

In The Lancet, William C Miller and colleagues1 describe their feasibility study of a randomised controlled trial for an integrated intervention of individualised system navigation and psychosocial counselling and antiretroviral therapy (ART) for people who inject drugs (PWID) and are HIV seropositive in Kyiv (Ukraine), Thai Nguyen (Vietnam), and Jakarta (Indonesia). Participants in the control group were given standard of care as per their local site guidelines. As expected, the authors found that the intervention increased the proportion of participants who were virally suppressed and on medication-assisted treatment (MAT) for substance use, and reduced mortality compared with standard of care.